ADRC News

Sterling Johnson, PhD, is co-author of a study that found that individuals who carry two copies of the APOE4 gene are likely to face symptoms and develop Alzheimer's disease at an earlier age.

The award is presented to an outstanding volunteer who continues to make a difference by moving the Alzheimer’s Association mission forward and supporting families throughout Wisconsin.

Natascha Merten, PhD, MS, was awarded a Fall Research Competition award for 2024-2025 from the University of Wisconsin Office of the Vice Chancellor for Research (OVCR) and Graduate Education.

Nearly 200 people attended the annual Solomon Carter Fuller Brain Health Brunch on April 6, 2024, at TPC Wisconsin in Madison. The yearly event aims to build awareness of Alzheimer’s disease in the African American community.

Lindsay Clark, PhD, and Sterling Johnson, PhD, examined data collected through the Wisconsin Registry for Alzheimer’s Prevention (WRAP) and the German longitudinal study DELCODE, which determined that smartphone task performance could be used to identify those with and without mild cognitive impairment (MCI).

The article, published in the February 2024 issue, mentions several studies, researchers and other accomplishments from the Wisconsin Alzheimer's Disease Research Center (ADRC).

Nathaniel Chin, MD, discusses new therapies, early detection, screening and managing different stages of dementia for Alzheimer’s disease in a two-part video series produced by The New England Journal of Medicine.

When researchers test motor skills, hearing, vision and smell in people in their midlife, they are better able to identify those who may develop cognitive decline or impairment 10 years later, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.

Nathaniel Chin, MD, penned a guest essay recently featured in Newsday explaining how emerging Alzheimer’s treatments raise the stakes for understanding the distinction between Alzheimer’s disease and dementia.

Researchers from the Wisconsin Alzheimer’s Disease Research Center ranked highly in the Blue Ridge Institute for Medical Research’s rankings for funding from the National Institutes on Health.